Extended Duration Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With Peripheral Arterial Disease: A Meta-Analysis

BACKGROUND: Patients with peripheral arterial disease (PAD) undergoing percutaneous coronary intervention (PCI) are at elevated risk of ischemic and bleeding events. However, the optimal duration of dual antiplatelet therapy (DAPT) after PCI in patients with PAD remains unclear. METHODS: A systemati...

Descripción completa

Detalles Bibliográficos
Autores principales: Ling, Hua, Andrews, Ebony, Ombengi, David, Li, Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5997438/
https://www.ncbi.nlm.nih.gov/pubmed/29904448
http://dx.doi.org/10.14740/cr719w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5997438/
https://www.ncbi.nlm.nih.gov/pubmed/29904448
http://dx.doi.org/10.14740/cr719w

Ejemplares similares